4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-18-056332
EVP, CFO & CBO sold 107,524 shares at $127.74 ($13,735,116)
- EVP, CFO & CBO acquired 89,400 shares (option exercise)
- EVP, CFO & CBO gave 12,012 shares (gift)
- EVP, CFO & CBO gave 12,012 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
Mahatme Sandesh · EVP, CFO & CBO
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-10-24 | Exercise or conversion : show line 1 in the form | +9,596 | $23.85 | $228,865 | 48,381 | D |
| 2018-10-24 | Exercise or conversion : show line 2 in the form | +39,006 | $13.90 | $542,183 | 87,387 | D |
| 2018-10-24 | Exercise or conversion : show line 3 in the form | +29,080 | $13.71 | $398,687 | 116,467 | D |
| 2018-10-24 | Exercise or conversion : show line 4 in the form | +11,718 | $13.71 | $160,654 | 128,185 | D |
| 2018-10-24 | Sale : show line 5 in the form | −107,524 | $127.74 | $13,735,116 | 20,661 | D |
| 2018-10-24 | Gift : show line 6 in the form | −12,012 | 8,649 | D | ||
| 2018-10-24 | Gift : show line 7 in the form | +12,012 | 12,012 | I | ||
| Open-market sales · 107,524 sh · avg $127.74 · $13,735,116 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-10-24 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −9,596 | $23.85 | 2022-11-05 | 9,596 | 116,009 | D |
| 2018-10-24 | Exercise or conversion : show line 9 in the form Stock Option (right to buy) | −39,006 | $13.90 | 2025-02-27 | 39,006 | 17,860 | D |
| 2018-10-24 | Exercise or conversion : show line 10 in the form Stock Option (right to buy) | −29,080 | $13.71 | 2026-02-28 | 29,080 | 7,899 | D |
| 2018-10-24 | Exercise or conversion : show line 11 in the form Stock Option (right to buy) | −11,718 | $13.71 | 2026-02-28 | 11,718 | 12,873 | D |
Loading xslF345X03/doc4.xml…